# Pathware

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/pathware

- Industry: Software
- Headquarters: Seattle, US
- Website: www.pathware.com
- Total disclosed funding: $8M
- Latest round: Series A (Apr 20, 2022)
- Investors on record: 4

## About

Based in Washington, US, and founded in 2017 headed by TJ Meyer as CEO, Pathware, Inc., formerly known as Medkairos, INC. is a MedTech company focus on digitalizing the pathology. In April 2020, Pathware, Inc. raised USD 7 million in series A funding led by UnityPoint Health Ventures and Level Eight Ventures with participation from MVolution Partners, Solas BioVentures, and other individual investors.


The company offers BiopticTM which offers the real time biopsy quality assessment. Through its hardware integration and software system company is enabling point of care by providing on-site quality assessment.


The April 2020 investment will continue expanding the company and finally, put forward the FDA integrated hardware and software system clearance.

## Funding rounds

- Series A, Apr 20, 2022, $8M — Solas BioVentures, UnityPoint Health Ventures, Level Eight Ventures, MVolution Partners

## Investors

- Solas BioVentures (https://capitalatlas.ai/funds/solas-bioventures) — Series A
- UnityPoint Health Ventures (https://capitalatlas.ai/funds/unitypoint-health-ventures) — Series A
- Level Eight Ventures (https://capitalatlas.ai/funds/level-eight-ventures) — Series A
- MVolution Partners (https://capitalatlas.ai/funds/mvolution-partners) — Series A